CoQ10 and muscle soreness after exercise

What the study showed about soreness on the first and third days after exercise.

Key points

  • In a study of untrained men aged 18–30 after two bouts of exercise, next-day soreness was lower with ubiquinol than placebo; ubiquinol was given after the first bout and the second followed an hour later. For a similar protocol there is a preliminary signal of less severe next-day soreness. [1] See the evidence 1
  • In the study of untrained men, soreness on day three was also lower with ubiquinol than placebo. For this protocol there is a preliminary signal of less severe soreness on day three as well. [1] See the evidence 1

Practical guide

Check the conclusions and whether they apply to your situation.

The study assessed soreness after a specific two-exercise protocol.

Key points

Why these conclusions

First and third days after exercise

Untrained men aged 18–30 received 300 mg of ubiquinol or placebo within ten minutes after the first exercise; the second exercise followed an hour later. Soreness on days one and three after the second exercise was lower with ubiquinol; certainty is very low. [1]

In young untrained men after two bouts of exercise, next-day soreness was lower with ubiquinol than placebo.

ParameterData
ResultIn young untrained men after two bouts of exercise, next-day soreness was lower with ubiquinol than placebo. In both BMI groups pain was lower after ubiquinol, each p<0.001 according to Figure 9.
Participants42 untrained men aged 18–30, 21 each in normal and elevated BMI groups
FormUbiquinol 300 mg orally within 10 minutes after the first exercise, second exercise one hour later
DoseUbiquinol 300 mg orally within 10 minutes after the first exercise, second exercise one hour later
Dose basisUbiquinol 300 mg orally within 10 minutes after the first exercise, second exercise one hour later
ComparatorPlacebo in randomized crossover order; separate sports drink condition
DurationAssessment on day 1 after the second exercise
Confidence1/4: Precision: No numerical between-group effect or confidence interval. Consistency: No grounds for a separate downgrade. Applicability to the specified group: Narrow two-exercise protocol in untrained men. Possible publication bias: No specific data for a separate downgrade. Study methods: Multiple subgroups, conditions and time points.
Evidence base1 trial; outcome from the same participant group
Sources[1]

In the same study, soreness on day three was lower with ubiquinol than placebo.

ParameterData
ResultIn the same study, soreness on day three was lower with ubiquinol than placebo. In both BMI groups pain was lower after ubiquinol, each p<0.001 according to Figure 9.
Participants42 untrained men aged 18–30, 21 each in normal and elevated BMI groups
FormUbiquinol 300 mg orally within 10 minutes after the first exercise, second exercise one hour later
DoseUbiquinol 300 mg orally within 10 minutes after the first exercise, second exercise one hour later
Dose basisUbiquinol 300 mg orally within 10 minutes after the first exercise, second exercise one hour later
ComparatorPlacebo in randomized crossover order; separate sports drink condition
DurationAssessment on day 3 after the second exercise
Confidence1/4: Precision: No numerical between-group effect or confidence interval. Consistency: No grounds for a separate downgrade. Applicability to the specified group: Narrow two-exercise protocol in untrained men. Possible publication bias: No specific data for a separate downgrade. Study methods: Multiple subgroups, conditions and time points.
Evidence base1 trial; outcome from the same participant group
Sources[1]

More details

What the result applies to

The study used a crossover comparison and a narrow two-exercise protocol; a numerical between-group effect was not reported. [1]

Sources

  1. Post-workout supplementation with CoQ10 and sports drink on exercise performance and muscle recovery after exercise in normal and overweight males. https://journal.hep.com.cn/smhs/EN/PDF/10.1016/j.smhs.2025.02.005

Methodology: Subpages evidence-led supplement pipeline v1

Ingredient overview: Ubidecarenone